Commercial Antibodies: The Good, Bad, and Really Ugly.
Research output: Contribution to journal › Comment/debate › Research
Standard
Commercial Antibodies: The Good, Bad, and Really Ugly. / Couchman, John R.
In: Journal of Histochemistry and Cytochemistry, 2008.Research output: Contribution to journal › Comment/debate › Research
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Commercial Antibodies: The Good, Bad, and Really Ugly.
AU - Couchman, John R
PY - 2008
Y1 - 2008
N2 - The range of antibodies available commercially grows ever larger. Perhaps as a consequence, quality control is not always what it could and should be. Investigators must be aware of potential pitfalls and take steps to assure themselves that the specificity of each antibody is as advertised. Additionally, companies should provide the necessary information about the antigen and antibody to investigators, including references, so that the appropriate controls can be included.
AB - The range of antibodies available commercially grows ever larger. Perhaps as a consequence, quality control is not always what it could and should be. Investigators must be aware of potential pitfalls and take steps to assure themselves that the specificity of each antibody is as advertised. Additionally, companies should provide the necessary information about the antigen and antibody to investigators, including references, so that the appropriate controls can be included.
U2 - 10.1369/jhc.2008.952820
DO - 10.1369/jhc.2008.952820
M3 - Comment/debate
C2 - 18854593
JO - Journal of Histochemistry and Cytochemistry
JF - Journal of Histochemistry and Cytochemistry
SN - 0022-1554
ER -
ID: 7691431